Hamilton Thorne (CVE:HTL) Trading Up 4.3% – Should You Buy?

Hamilton Thorne Ltd. (CVE:HTL) rose 4.3% on Tuesday . The stock traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares changed hands during mid-day trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Stock Up 4.3%

The business’s fifty day simple moving average is C$1.45 and its 200 day simple moving average is C$1.45. The company has a current ratio of 3.20, a quick ratio of 2.25 and a debt-to-equity ratio of 16.60. The stock has a market cap of C$149.69 million, a price-to-earnings ratio of 58.94 and a beta of 0.54.

About Hamilton Thorne

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.